Allyson Pishko/pennmedicine.org
Aug 14, 2025, 12:52
JAMA Review: Immune Thrombotic Thrombocytopenic Purpura (iTTP)
JAMA shared an insightful post on X:
“Immune thrombotic thrombocytopenic purpura (iTTP) is a rare immune-mediated disorder characterized by thrombocytopenia and microangiopathic hemolytic anemia, potentially causing life-threatening thrombosis.”
Read the full review here.
Article: Immune Thrombotic Thrombocytopenic Purpura
Authors: Allyson M. Pishko, Ang Li, Adam Cuker
Stay informed on all science in the field of platelet disorders with Hemostasis Today.
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’